Skip to main content
Clinical Trials/NCT06263361
NCT06263361RecruitingNot Applicable

Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma (PCNSL): Integration of Advanced MRI Patterns and Fluorescein Sodium Fluorescence

IRCCS San Raffaele1 site in 1 country15 target enrollmentStarted: October 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
15
Locations
1
Primary Endpoint
MRI imaging

Study Overview

Brief Summary

Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non- Hodgkin lymphoma exclusively localized into the nervous system. The aim of this study is to evaluate the MRI imaging characteristics of the peritumoral area (PTA) and to correlate this information to pathological findings.

Detailed Description

Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non- Hodgkin lymphoma exclusively localized into the nervous system. It is a relatively rare disorder, accounting for only 3% of all primary brain tumors but due to its anatomical localization represents an important clinical and diagnostic challenge in onco-hematology. different MRI patterns of the peritumoral area (PTA) might correlate with different histopathological sensitivity regarding diagnostic potential out of contrast-enhanced region (CER). Improvements in the understanding of PTA diagnostic potentials is of great help in diagnosing patients with deep-seated lesions, who would otherwise be not eligible for stereotactic biopsy and therefore for a consequent adequate treatment.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients, undergoing stereotactic biopsy for newly diagnosed PSNCLs

Exclusion Criteria

  • Severe hepatic dysfunction
  • Severe renal dysfunction
  • Severe heart failure
  • myocardial infarction and stroke within 90 days
  • Hyperreactivity against contrast agents
  • Pregnancy

Outcomes

Primary Outcomes

MRI imaging

Time Frame: Baseline (before surgery)

Peritumoral area (PTA) mean ADC value in PTA. Units: mm2/s

Define immunopathological features

Time Frame: 1 week after surgical procedure

Number of immune cells infiltrating the lesion. Units: number/mm3

Secondary Outcomes

  • Accuracy of fluoresceine guided stereotactic biopsy(1 week after surgical procedure)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pietro Mortini, MD, Prof.

Professor, Head of Department

IRCCS San Raffaele

Study Sites (1)

Loading locations...

Similar Trials